BioCentury
ARTICLE | Clinical News

PAT-SM6: Phase I/IIa started

November 12, 2012 8:00 AM UTC

Patrys began an open-label, dose-escalation, German Phase I/IIa trial to evaluate multiple doses of PAT-SM6 in about 12 patients with relapsed and refractory MM. ...